West Pharmaceutical Services Current maturities of long-term debt remained flat by 0.0% to $1.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 36.4%, from $1.10M to $1.50M. This is a positive signal — lower values indicate better performance for this metric.
An increase signals higher immediate debt service requirements, which may necessitate refinancing or use of cash reserves.
This reflects the portion of long-term debt and finance lease obligations that must be repaid within the next fiscal yea...
Commonly tracked across all capital-intensive industries to evaluate short-term solvency.
other_finance_lease_liability_current| Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $900.00K | $900.00K | $900.00K | $1.10M | $1.30M | $1.50M | $1.50M | $1.50M |
| QoQ Change | — | +0.0% | +0.0% | +22.2% | +18.2% | +15.4% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +44.4% | +66.7% | +66.7% | +36.4% |